Dietary phosphorus reduction by pretreatment of human breast milk with sevelamer

Pediatric Nephrology

Volumn 19, Issue 7, 2004, Pages 775-779

  Ferrara, Elizabeth ^a   Lemire, Jacques ^a,b   Reznik, Vivian M ^a,b   Grimm, Paul C ^a,b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Hyperphosphatemia; Infants; Pretreatment; RenaGel (Genzyme); Renal failure; Sevelamer; Toddlers

Indexed keywords

CALCIUM; ELECTROLYTE; PHOSPHORUS; PROTEIN; SEVELAMER;

ARTICLE; ARTIFICIAL MILK; BREAST MILK; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIET RESTRICTION; FOOD COMPOSITION; FOOD FREEZING; GASTROSTOMY; HUMAN; HYDROGEL; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; INFANT FEEDING; MACRONUTRIENT; NUTRIENT CONTENT; OSMOLALITY; PH; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; SAFETY; SUPERNATANT; SWALLOWING; TEMPERATURE; VISCOSITY;

EPOXY COMPOUNDS; FEMALE; FREEZING; HUMANS; INFANT; INFANT, NEWBORN; MILK, HUMAN; PHOSPHORUS, DIETARY; POLYAMINES; POLYETHYLENES;

EID: 3142693564     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1448-6     Document Type: Article

References (15)

1. Hsu CY, Chertow GM (2002) Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. Nephrol Dial Transplant 17:1419-1425
2. Kent JC, Arthur PG, Retallack RW, Hartmann PE (1992) Calcium, phosphte, and citrate in human milk at initiation of lactation. J Dairy Res 59:161-167
3. Siberry GK, Iannone RI (eds) (2000) The Harriet Lane Handbook. Mosby, Missouri, p 500
4. Griswold WR, Reznik V, Mendoza SA, Trauner D, Alfrey AC (1983) Accumulation of aluminum in a nondialyzed uremic child receiving aluminum hydroxide. Pediatrics 71:56-58
5. Nathan E, Pedersen SE (1980) Dialysis encephalopathy in a non-dialysed uraemic boy treated with aluminium hydroxide orally. Acta Paediatr Scand 69:793-796
6. Salusky IB, Goodman WG (2002) Cardiovascular calcification in end-stage renal disease. Nephrol Dial Transplant 17:336-339
7. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100-105
8. Chertow GM, Burke SK, Lazarus JM, Stenzel KH, Wombolt D, Goldberg D, Bonventre JV, Slatopolsky E (1997) Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. Am J Kidney Dis 29:66-71
9. Slatopolsky EA, Burke SK, Dillon MA (1999) RenaGel, a non-absorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group. Kidney Int 55:299-307
10. Bunchman TE, Wood EG, Schenck MH, Weaver KA, Klein BL, Lynch RE (1991) Pretreatment of formula with sodium polystyrene sulfonate to reduce dietary potassium intake. Pediatr Nephrol 5:29-32
11. Hurley WL. Lactation biology at the University of Illinois Urbana-Champaign. Lecture on human milk and lactation, http://classes.aces.uiuc.edu/AnSci308/HumanLact.html.
12. Bleyer AJ, Burke SK, Dillon M, Garrett B, Kant KS, Lynch D, Rahman SN, Schoenfeld P, Teitelbaum I, Zeig S, Slatopolsky E (1999) A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients. Am J Kidney Dis 33:694-701
13. Schroder CH, Berg AM van den, Williems JL, Monnens LA (1993) Reduction of potassium in drinks by pre-treatment with calcium polystyrene sulphonate. Eur J Pediatr 152:263-264
14. Bonnet L, Goudable J, Accominotti M, Fontaine D, Cochat P (1997) Effect of ion exchange resins on the composition of milk (abstract). Nephrologie 18:287
15. Fassinger N, Dabbagh S, Mukhopadhyay S, Lee DY (1998) Mineral content of infant formula after treatment with sodium polystyrene sulfonate or calcium polystyrene sulfonate. Adv Perit Dial 14:274-277